Cell Matters Competitors and Similar CompaniesClear all
Pluri Biotech's competitors and similar companies include EpiBiologics and EdiGENE.
 Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies. |  EdiGENE EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation). | ||
Founding Date | Founding Date 2003 | Founding Date 2022 | Founding Date 2015 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Haifa, IL HQ Potsdam, DE | Locations San Mateo, US HQ | Locations Cambridge, US HQ |
Employees | Employees 106 | Employees 40 | Employees 49 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (over 3 years ago) | Latest funding round $ 22m (about 5 years ago) |
Total funding raised | Total funding raised $ 78.4m | Total funding raised $ 50m | Total funding raised $ 143.5m |
For sources of this data, please see the company profile
View Company Profiles
EpiBiologics
HQ
San Mateo, US
Employees
40
EpiBiologics is a company that provides a protein degradation platform.
View companyEdiGENE
HQ
Cambridge, US
Employees
49
EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation).
View company